Index Entries - Covid Index

1989 Results

Title	IS Publication Date
An observational and Mendelian randomisation study on vitamin D and COVID-19 risk in UK Biobank	September 14, 2021
An observational study of breakthrough SARS-CoV-2 Delta variant infections among vaccinated healthcare workers in Vietnam	September 29, 2021
An open debate on SARS-CoV-2’s proximal origin is long overdue	February 7, 2021
An outbreak caused by the SARS-CoV-2 Delta variant (B.1.617.2) in a secondary care hospital in Finland, May 2021	July 1, 2021
An overview of the anti-SARS-CoV-2 properties of Artemisia annua, its antiviral action, protein-associated mechanisms, and repurposing for COVID-19 treatment	July 22, 2021
An overview of the MATH+, I-MASK+ and I-RECOVER Protocols — A Guide to the Management of COVID-19
An Update on COVID-19 Vaccine Induced Thrombotic Thrombocytopenia Syndrome and Some Management Recommendations	August 18, 2021
Anakinra for severe forms of COVID-19: a cohort study	May 29, 2020
Analysis of COVID-19 vaccine death reports from the Vaccine Adverse Events Reporting System (VAERS) Database Interim: Results and Analysis	June 2021
Analysis of Neurological Adverse Events Reported in VigiBase From COVID-19 Vaccines	January 18, 2022
Analysis of the initial lot of the CDC 2019-Novel Coronavirus (2019-nCoV) real-time RT-PCR diagnostic panel	December 15, 2021
Analysis of Thromboembolic and Thrombocytopenic Events After the AZD1222, BNT162b2, and MRNA-1273 COVID-19 Vaccines in 3 Nordic Countries	June 14, 2022
Analysis of vitamin D level among asymptomatic and critically ill COVID?19 patients and its correlation with infammatory markers
Anaphylaxis to Pfizer/BioNTech mRNA COVID-19 Vaccine in a Patient With Clinically Confirmed PEG Allergy	September 28, 2021
Anaphylaxis-Induced Acute Coronary Syndrome Following Covid-19 mRNA-LNP Vaccination: Mechanisms and Therapeutic Approaches	October 1, 2024
Anecdotals (documentary)	December 2022
Anthem BCBS Medicaid - COVID-19 Vaccine Provider Incentive program	October 21, 2021
Anthony Fauci emails acquired by FOIA request
Anthony Fauci on C-SPAN’s Washington Journal	October 11, 2004
Anti-recoverin Antibody-Associated Post-acute COVID Vaccination Syndrome After BNT162b2 in HLA-B27-Positive Spondylarthritis: A Case Report	August 14, 2024
Anti-SARS-CoV-2 Receptor-Binding Domain Antibody Evolution after mRNA Vaccination	October 7, 2021
Anti-science case study: COVID-19 vaccines’ effectiveness and safety exaggerated	May 23, 2024
Antibody epitopes in vaccine-induced immune thrombotic thrombocytopaenia	July 7, 2021
Antibody levels decrease after two doses of Pfizer vaccine – study	October 7, 2021
Antibody Status and Incidence of SARS-CoV-2 Infection in Health Care Workers	February 11, 2021
Antibody-dependent enhancement
Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies	September 9, 2020
Antigenic minimalism of SARS-CoV-2 is linked to surges in COVID-19 community transmission and vaccine breakthrough infections	May 31, 2021
Antiviral Effect of Budesonide against SARS-CoV-2	July 20, 2021
Antiviral effect of high-dose ivermectin in adults with COVID-19: A proof-of-concept randomized trial	June 18, 2021
Antiviral treatments [Molnupiravir] lead to the rapid accrual of hundreds of SARS-CoV-2 mutations in immunocompromised patients
Antiviral, virucidal and antioxidant properties of Artemisia annua against SARS-CoV-2	October 11, 2023
Aphasia seven days after second dose of an mRNA-based SARS-CoV-2 vaccine	June 24, 2021
Apparent risks of postural orthostatic tachycardia syndrome diagnoses after COVID-19 vaccination and SARS-Cov-2 Infection	December 12, 2022
Appendix 1: estimation of number needed to vaccinate to prevent a COVID-19 hospitalisation for primary vaccination, booster vaccination (3rd dose), autumn 2022 and spring 2023 booster for those newly in a risk group	January 25, 2023
APPENDIX 2.2: Cumulative and Interval Summary Tabulation of Serious and Non-Serious Adverse Reactions from Post-Marketing Data Sources	June 21, 2022
Approval letter: Biologics License Application (BLA) Approval for BioNTech (Pfizer) Manufacturing GmbH	August 23, 2021
Are COVID-19 Vaccines in Pregnancy as Safe and Effective as the Medical Industrial Complex Claim? Part I	February 8, 2025
Are COVID-19 Vaccines in Pregnancy as Safe and Effective as the U.S. Government, Medical Organizations, and Pharmaceutical Industry Claim? Part II	July 1, 2024
Are Face Masks Effective? The Evidence.	Published July 2020, updated September 2023
Are Lockdowns Effective in Managing Pandemics?	July 29, 2022
Arrhythmias after COVID-19 Vaccination: Have We Left All Stones Unturned?	June 20, 2023
Artemisia annua L. and Its Derivatives: Their Antiviral Effects on COVID-19 and Possible Mechanisms	January 24, 2022
Assessing Case Fatality on Cases of Thrombosis with Concurrent Thrombocytopenia Following COVID-19 Vaccine AstraZeneca (Vaxzevria) in the United Kingdom: A Review of Spontaneously Reported Data	August 4, 2022
Assessing mandatory stay-at-home and business closure effects on the spread of COVID-19	January 5, 2021
Assessment of cardiac adverse events following COVID‑19 vaccination by speckle tracking echocardiography	May 13, 2024
Assessment of Myocardial 18F-FDG Uptake at PET/CT in Asymptomatic SARS-CoV-2–vaccinated and Nonvaccinated Patients	September 19, 2023
Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational study	March 27, 2021
Assessment report: COVID-19 Vaccine Moderna	March 11, 2021
Association between COVID-19 Vaccination and Neuropsychiatric Conditions	April 14, 2025

Page 4 of 40